Company record · updated August 5, 2026
Click Therapeutics C: 10 valuation observations from SEC filings
Every row below names the filing it came from. Coverage for this company runs December 31, 2023 to March 31, 2026.
10observations
10source filings
10verified rows
2026-03-31most recent as-of date
Source rails for this company: N-PORT fund mark (10).
Reported by 1 filer: The Private Shares Fund.
| As of | Measure | Value | Reported by | Tier | What the filing says | Accession |
|---|---|---|---|---|---|---|
| 2026-03-31 | price per share | 4.9671 USD | The Private Shares Fund | VERIFIED | valUSD 4967100.0 / balance 1000000.0 [common] | 000119312526241036 |
| 2025-12-31 | price per share | 4.9671 USD | The Private Shares Fund | VERIFIED | valUSD 4967100.0 / balance 1000000.0 [common] | 000092687726000030 |
| 2025-09-30 | price per share | 4.9671 USD | The Private Shares Fund | VERIFIED | valUSD 4967100.0 / balance 1000000.0 [common] | 000119312525289155 |
| 2025-06-30 | price per share | 4.9671 USD | The Private Shares Fund | VERIFIED | valUSD 4967100.0 / balance 1000000.0 [common] | 000114554925053272 |
| 2025-03-31 | price per share | 3.82 USD | The Private Shares Fund | VERIFIED | valUSD 3820000.0 / balance 1000000.0 [common] | 000114554925032340 |
| 2024-12-31 | price per share | 3.85 USD | The Private Shares Fund | VERIFIED | valUSD 3850000.0 / balance 1000000.0 [common] | 000114554925009703 |
| 2024-09-30 | price per share | 3.91 USD | The Private Shares Fund | VERIFIED | valUSD 3910000.0 / balance 1000000.0 [common] | 000114554924071138 |
| 2024-06-30 | price per share | 3.92 USD | The Private Shares Fund | VERIFIED | valUSD 3920000.0 / balance 1000000.0 [common] | 000114554924048684 |
| 2024-03-31 | price per share | 3.91 USD | The Private Shares Fund | VERIFIED | valUSD 3910000.0 / balance 1000000.0 [common] | 000114554924027534 |
| 2023-12-31 | price per share | 3.8 USD | The Private Shares Fund | VERIFIED | valUSD 3800000.0 / balance 1000000.0 [common] | 000114554924010573 |
Reading these figures
A fund mark is the filer's own fair-value estimate at a quarter end, not a transaction price, and two filers can reach different values for the same date. A charter round price is the issue price of that series at issuance. Neither is a current market price. The capabilities page states the full limits.